171 related articles for article (PubMed ID: 31376015)
21. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
Kim KS; Kim J; Oh N; Kim MY; Park KS
Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
[TBL] [Abstract][Full Text] [Related]
22.
Shahi P; Wang CY; Lawson DA; Slorach EM; Lu A; Yu Y; Lai MD; Gonzalez Velozo H; Werb Z
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3169-3174. PubMed ID: 28258171
[TBL] [Abstract][Full Text] [Related]
23. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling.
Chiche A; Di-Cicco A; Sesma-Sanz L; Bresson L; de la Grange P; Glukhova MA; Faraldo MM; Deugnier MA
Breast Cancer Res; 2019 Jan; 21(1):13. PubMed ID: 30683141
[TBL] [Abstract][Full Text] [Related]
24. Breast-Specific Molecular Clocks Comprised of
Miyano M; Sayaman RW; Shalabi SF; Senapati P; Lopez JC; Angarola BL; Hinz S; Zirbes A; Anczukow O; Yee LD; Sedrak MS; Stampfer MR; Seewaldt VL; LaBarge MA
Cancer Prev Res (Phila); 2021 Aug; 14(8):779-794. PubMed ID: 34140348
[TBL] [Abstract][Full Text] [Related]
25. Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells.
Pires MM; Hopkins BD; Saal LH; Parsons RE
Cancer Biol Ther; 2013 Mar; 14(3):246-53. PubMed ID: 23291982
[TBL] [Abstract][Full Text] [Related]
26. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.
Lin HY; Zeng D; Liang YK; Wei XL; Chen CF
Oncotarget; 2017 May; 8(21):34750-34761. PubMed ID: 28423734
[TBL] [Abstract][Full Text] [Related]
27. Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling.
Chakrabarti R; Wei Y; Romano RA; DeCoste C; Kang Y; Sinha S
Stem Cells; 2012 Jul; 30(7):1496-508. PubMed ID: 22523003
[TBL] [Abstract][Full Text] [Related]
28. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.
Chou J; Lin JH; Brenot A; Kim JW; Provot S; Werb Z
Nat Cell Biol; 2013 Feb; 15(2):201-13. PubMed ID: 23354167
[TBL] [Abstract][Full Text] [Related]
29. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
Shahi P; Wang CY; Chou J; Hagerling C; Gonzalez Velozo H; Ruderisch A; Yu Y; Lai MD; Werb Z
Oncogene; 2017 Oct; 36(40):5567-5575. PubMed ID: 28581515
[TBL] [Abstract][Full Text] [Related]
30. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
Castilla MÁ; López-García MÁ; Atienza MR; Rosa-Rosa JM; Díaz-Martín J; Pecero ML; Vieites B; Romero-Pérez L; Benítez J; Calcabrini A; Palacios J
Endocr Relat Cancer; 2014 Aug; 21(4):587-99. PubMed ID: 24891455
[TBL] [Abstract][Full Text] [Related]
31. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.
Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O
Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639
[TBL] [Abstract][Full Text] [Related]
32. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
33. GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.
McCleskey BC; Penedo TL; Zhang K; Hameed O; Siegal GP; Wei S
Am J Clin Pathol; 2015 Nov; 144(5):756-63. PubMed ID: 26486740
[TBL] [Abstract][Full Text] [Related]
34. ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.
Gallego-Ortega D; Ledger A; Roden DL; Law AM; Magenau A; Kikhtyak Z; Cho C; Allerdice SL; Lee HJ; Valdes-Mora F; Herrmann D; Salomon R; Young AI; Lee BY; Sergio CM; Kaplan W; Piggin C; Conway JR; Rabinovich B; Millar EK; Oakes SR; Chtanova T; Swarbrick A; Naylor MJ; O'Toole S; Green AR; Timpson P; Gee JM; Ellis IO; Clark SJ; Ormandy CJ
PLoS Biol; 2015 Dec; 13(12):e1002330. PubMed ID: 26717410
[TBL] [Abstract][Full Text] [Related]
35. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.
Xu G; Chhangawala S; Cocco E; Razavi P; Cai Y; Otto JE; Ferrando L; Selenica P; Ladewig E; Chan C; Da Cruz Paula A; Witkin M; Cheng Y; Park J; Serna-Tamayo C; Zhao H; Wu F; Sallaku M; Qu X; Zhao A; Collings CK; D'Avino AR; Jhaveri K; Koche R; Levine RL; Reis-Filho JS; Kadoch C; Scaltriti M; Leslie CS; Baselga J; Toska E
Nat Genet; 2020 Feb; 52(2):198-207. PubMed ID: 31932695
[TBL] [Abstract][Full Text] [Related]
36. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer.
Bai F; Zhang LH; Liu X; Wang C; Zheng C; Sun J; Li M; Zhu WG; Pei XH
Theranostics; 2021; 11(17):8218-8233. PubMed ID: 34373738
[No Abstract] [Full Text] [Related]
37. Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.
Bhardwaj A; Ganesan N; Tachibana K; Rajapakshe K; Albarracin CT; Gunaratne PH; Coarfa C; Bedrosian I
PLoS One; 2015; 10(5):e0127678. PubMed ID: 26000884
[TBL] [Abstract][Full Text] [Related]
38. GATA3 in development and cancer differentiation: cells GATA have it!
Chou J; Provot S; Werb Z
J Cell Physiol; 2010 Jan; 222(1):42-9. PubMed ID: 19798694
[TBL] [Abstract][Full Text] [Related]
39. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
Pellegrini P; Cordero A; Gallego MI; Dougall WC; Muñoz P; Pujana MA; Gonzalez-Suarez E
Stem Cells; 2013 Sep; 31(9):1954-65. PubMed ID: 23766243
[TBL] [Abstract][Full Text] [Related]
40. High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.
Lobba ARM; Carreira ACO; Cerqueira OLD; Fujita A; DeOcesano-Pereira C; Osorio CAB; Soares FA; Rameshwar P; Sogayar MC
PLoS One; 2018; 13(6):e0199254. PubMed ID: 29949609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]